PHC6 COST-EFFECTIVENESS OF RIVAROXABANVERSUS ENOXAPARIN FORTHROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT IN SPAIN
Abstract
Authors
A Diamantopoulos F Forster M Brosa M Lees C Piol L Febrer
A Diamantopoulos F Forster M Brosa M Lees C Piol L Febrer
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now